Enhancement of Solubility, Dissolution, and Anti-Inflammatory Activity of Aceclofenac via Multicomponent Crystal Formation with Tromethamine
Main Article Content
Abstract
Aceclofenac (ACE) is a non-steroidal anti-inflammatory drug (NSAID) widely used for osteoarthritis and rheumatoid arthritis, yet its therapeutic performance is limited by poor aqueous solubility as a Biopharmaceutics Classification System (BCS) Class II drug. This study aimed to enhance the physicochemical and pharmacological properties of ACE by forming a multicomponent crystal (MC) with tromethamine (TRIS). The MC was produced via solvent-dropped grinding in a 1:1 molar ratio and characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and Fourier-transform infrared spectroscopy (FTIR). DSC and PXRD results indicated the formation of a eutectic system with reduced crystallinity, while FTIR showed intermolecular hydrogen bonding, evidenced by the broad OH stretching band near 3000 cm⁻¹, without new covalent bond formation. Solubility increased 35.8-fold relative to pure ACE, and dissolution testing showed a markedly improved dissolution efficiency (DE₆₀) of 75.33 ± 1.57% compared with 49.10 ± 0.54% for ACE alone. In vivo anti-inflammatory assessment using a carrageenan-induced granuloma pouch model further demonstrated superior pharmacological activity of the MC, significantly reducing exudate volume (0.56 mL) and TNF-α levels (25.26 pg/mL) versus pure ACE (0.82 mL and 29.70 pg/mL). Overall, the ACE–TRIS multicomponent crystal effectively enhances solubility, dissolution, and anti-inflammatory efficacy, offering a promising approach for improving ACE’s therapeutic performance.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
[1] Jessica A, Yasa SWN, Zaini E, Fitriani L. Increased Dissolution
Rate of Aceclofenac by Formation of Multicomponent Crystals
With L-Glutamine. Int J Appl Pharm. 16(Special Issue 1):45–52.
[2] Rusli D, Umar S, Aldi Y, Usman H, Siregar MN, Zaini E.
Enhancement of Aceclofenac Dissolution Rate via Solid
Dispersion with Hydroxypropyl Methylcellulose. Trop J Nat
Prod Res. 9(1):152–6.
[3] Bagwe P V., Thakur VP, Kharkar PS, Joshi S V. Synthesis,
characterization, and dissolution properties of Aceclofenacisobutabolammonium salt. J Indian Chem Soc.
100(11):101093. https://doi.org/10.1016/j.jics.2023.101093
[4] Fitriani L, Fadina H, Usman H, Zaini E. Formation and
Characterization of Multicomponent Crystal of Trimethoprim
and Mandelic Acid By Solvent Drop Grinding Method. Int J Appl
Pharm. 15(Special Issue 1):75–9.
[5] Guo M, Sun X, Chen J, Cai T. Pharmaceutical Cocrystals: A
Review of Preparations, Physicochemical Properties and
Applications. Acta Pharm Sin B. 11(8):2537–64.
https://doi.org/10.1016/j.apsb.2021.03.030
[6] Syed RU, Moni SS, Alharbi N, Alraddadi M, Aldhafeeri DM,
Alshammari MO, et al. Exploring the Multifaceted Healing
Powers of Turnip Leaves from Saudi Arabia: Chemical
Composition, Anti-Ulcer, Antibacterial, and Apoptosis
Regulatory Properties. Orient J Chem. 41(4):1067–78.
[7] Y, Xue S, Li S, Pang S. Study on Preparation of Pillararene
Cocrystals by Liquid-Assisted Grinding. J Phys Conf Ser.
2539(1):1.
[8] Fandaruff C, Vega-baudrit JR, Navarro-hoyos M, Lamas DG,
Araya-sibaja AM. Saquinavir-Piperine Eutectic Mixture :
Preparation, Characterization, and Dissolution Profile.
Pharmaceutics. 15:1–15.
[9] Banerjee M, Nimkar K, Naik S, Patravale V. Unlocking the
potential of drug-drug cocrystals – A comprehensive review. J
Control Release. 348(March):456–69.
https://doi.org/10.1016/j.jconrel.2022.06.003
[10] Rumondor ACF, Taylor LS. Effect of Polymer Hygroscopicity on
the Phase Behavior of Amorphous Solid Dispersions in the
Presence of Moisture. Mol Pharm. 7(2):477–90.
[11] Zalte AG, Darekar AB, Gondkar SB. Cocrystals : An Alternative
Approach to Modify Physicochemical Properties of Drugs. Am
J PharmTech Res. 4(January):427–36.
[12] Saikia B, Seidel-Morgenstern A, Lorenz H. Multicomponent
Materials to Improve Solubility: Eutectics of Drug
Aminoglutethimide. Crystals. 12(1):40.
[13] Zaini E, Riska D, Oktavia MD, Ismed F, Fitriani L. Improving
Dissolution Rate of Piperine by Multicomponent Crystal
Formation with Saccharin. RJPT. 13(April):1928–32.
[14] Fitriani L, Firdaus WA, Sidadang W, Rosaini H, Putra OD.
Improved Solubility and Dissolution Rate of Ketoprofen by the
Formation of Multicomponent Crystals with Tromethamine.
Crystals. 12(275):1–14.
[15] Bookwala M, Thipsay P, Ross S, Zhang F. Preparation of a
Crystalline Salt of Indomethacin and Tromethamine by Hot
Melt Extrusion Technology. Eur J Pharm Biopharm. :1–37.
[16] Ferreira S, Filho S, Pereira AC, Sarraguça JMG, Sarraguça C,
Lopes J, et al. Synthesis of a glibenclamide cocrystal: full
spectroscopic and thermal characterization Silvério. J Pharm
Sci. :1–29.
[17] Abdelkader H, Abdallah OY, Salem HS. Comparison of the
effect of tromethamine and polyvinylpyrrolidone on
dissolution properties and analgesic effect of nimesulide. AAPS
PharmSciTech. 8(3):1–8.
[18] Yuliandra Y, Izadihari R, Rosaini H, Zaini E. Multicomponent
crystals of mefenamic acid–tromethamine with improved
dissolution rate. J Res Pharm. 23(6):988–96.
[19] Bruni G, Berbenni V, Maggi L, Mustarelli P, Friuli V, Ferrara C,
et al. Multicomponent crystals of gliclazide and tromethamine:
preparation, physico-chemical, and pharmaceutical
characterization*. Drug Dev Ind Pharm. 44(2):243–50.
[20] Butler ZR, Kaduk JA, Gindhart AM, Blanton TN. Crystal
Structure of Fosfomycin Tromethamine,
(C4H12NO3)(C3H6O4P), from Synchrotron Powder Diffraction
Data and Density Functional Theory. Crystals. (3):1–9.
[21] Nair A, Jacob S. A simple practice guide for dose conversion
between animals and human. J Basic Clin Pharm. 7(2):27
[22] Zaini E, Wahyuni F, Salsabila H, Anggraini D, Yuliandra Y, Lucida
H. Eutectic Mixture of Fenofibric Acid and Syringic Acid:
Improvement of Dissolution Rate and Its Antihyperlipidemic
Activity. ChemistrySelect. 8(20):1–5.
[23] Umar S, Putri N, Deni B, Erizal A. Multicomponent Crystal of
Fenofibric Acid- Saccharin : Characterization and
Antihyperlipidemic Effectiveness. Adv Heal Sci Res.
40(Iccscp):104–9.
[24] Xia N, Liu Y, Gao D, Zhu S. Molecular Interaction and
Solubilization Efficiency of Neohesperidin in Ternary Systems
with Hydroxypropyl-β-cyclodextrin and Meglumine. Vol. 13,
Foods. 2024.
[25] Zaini E, Sumirtapura YC, Halim A, Fitriani L, Soewandhi SN.
Formation and characterization of sulfamethoxazoletrimethoprim cocrystal by milling process. J Appl Pharm Sci.
7(12):169–73.
[26] Acebedo-Martínez FJ, Alarcón-Payer C, Barrales-Ruiz HM,
Niclós-Gutiérrez J, Domínguez-Martín A, Choquesillo-Lazarte
D. Towards the Development of Novel Diclofenac
Multicomponent Pharmaceutical Solids. Crystals. 12(8):1–15.
[27] Vazquez E, Navarro M, Salazar Y, Crespo G, Bruges G, Osorio C,
et al. Systemic changes following carrageenan-induced paw
inflammation in rats. Inflamm Res. 64(5):333–42.
[28] Held F, Hoppe E, Cvijovic M, Jirstrand M, Gabrielsson J.
Challenge model of TNFα turnover at varying LPS and drug
provocations. J Pharmacokinet Pharmacodyn. 46(3):223–40.
https://doi.org/10.1007/s10928-019-09622-x
[29] van Loo G, Bertrand MJM. Death by TNF: a road to
inflammation. Nat Rev Immunol. 23(5):289–303.